Peter R. Casson

6.6k total citations · 1 hit paper
84 papers, 3.4k citations indexed

About

Peter R. Casson is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter R. Casson has authored 84 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Reproductive Medicine, 37 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter R. Casson's work include Ovarian function and disorders (32 papers), Hormonal and reproductive studies (31 papers) and Reproductive Biology and Fertility (13 papers). Peter R. Casson is often cited by papers focused on Ovarian function and disorders (32 papers), Hormonal and reproductive studies (31 papers) and Reproductive Biology and Fertility (13 papers). Peter R. Casson collaborates with scholars based in United States, Italy and Canada. Peter R. Casson's co-authors include John E. Buster, Peter J. Hornsby, Guy E. Abraham, James A. Simon, Akira Endoh, Norman A. Mazer, Raymond C. Rosen, Sandra R. Leiblum, Geoffrey P. Redmond and Elizabeth S. Ginsburg and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peter R. Casson

82 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy

2000 637 citations James A. Simon, Peter R. Casson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter R. Casson United States	30	1.7k	1.3k	901	665	521	84	3.4k
Maria Cristina Meriggiola Italy	40	1.5k 0.9×	1.6k 1.3×	1.1k 1.2×	467 0.7×	690 1.3×	127	4.2k
Howard A. Zacur United States	41	1.5k 0.9×	1.3k 1.1×	1.5k 1.7×	242 0.4×	487 0.9×	149	4.7k
Sandro Francavilla Italy	34	915 0.5×	1.6k 1.3×	1.0k 1.2×	599 0.9×	771 1.5×	131	3.6k
John E. Buster United States	37	2.0k 1.2×	1.8k 1.4×	2.2k 2.4×	855 1.3×	616 1.2×	134	5.6k
Andrea D. Coviello United States	28	2.9k 1.7×	1.3k 1.0×	539 0.6×	427 0.6×	958 1.8×	43	4.4k
Rod Baber Australia	28	1.5k 0.9×	786 0.6×	826 0.9×	201 0.3×	258 0.5×	77	3.2k
Vincenzo Rochira Italy	37	1.9k 1.1×	982 0.8×	351 0.4×	613 0.9×	937 1.8×	150	3.9k
James Liu United States	31	732 0.4×	881 0.7×	499 0.6×	302 0.5×	261 0.5×	119	2.8k
Robert E. Brannigan United States	31	974 0.6×	1.7k 1.4×	1.2k 1.3×	440 0.7×	715 1.4×	170	3.5k
Nanette Santoro United States	26	979 0.6×	919 0.7×	626 0.7×	139 0.2×	289 0.6×	75	2.3k

Countries citing papers authored by Peter R. Casson

Since Specialization

Citations

This map shows the geographic impact of Peter R. Casson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Casson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Casson more than expected).

Fields of papers citing papers by Peter R. Casson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Casson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Casson. The network helps show where Peter R. Casson may publish in the future.

Co-authorship network of co-authors of Peter R. Casson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Casson. A scholar is included among the top collaborators of Peter R. Casson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Casson. Peter R. Casson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quaas, Alexander, Jennifer D. Peck, Michael P. Diamond, et al.. (2020). Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes. Fertility and Sterility. 115(1). 213–220. 18 indexed citations

Hansen, Karl R., Aaron K. Styer, Robert A. Wild, et al.. (2016). Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation–intrauterine insemination. Fertility and Sterility. 105(6). 1575–1583.e2. 79 indexed citations

Steiner, Anne Z., Michael P. Diamond, Richard S. Legro, et al.. (2015). Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes. Fertility and Sterility. 104(6). 1522–1526. 33 indexed citations

Casson, Peter R., et al.. (2013). Soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian response to controlled ovarian hyperstimulation. Fertility and Sterility. 100(3). S136–S136. 3 indexed citations

Diamond, Michael P., Michael Krüger, Nanette Santoro, et al.. (2012). Endometrial Shedding Effect on Conception and Live Birth in Women With Polycystic Ovary Syndrome. Obstetrics and Gynecology. 119(5). 902–908. 29 indexed citations

Osol, George, et al.. (2012). Metformin treatment prevents the development of endothelial dysfunction in a rat model of polycystic ovary syndrome (PCOS). Fertility and Sterility. 98(3). S60–S60. 1 indexed citations

Palmer, Bradley M., et al.. (2012). Effects of testosterone on cardiomyocyte calcium homeostasis and contractile function in female rats. Experimental Physiology. 98(1). 161–171. 7 indexed citations

Schlaff, William D., Heping Zhang, Michael P. Diamond, et al.. (2011). Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies. Fertility and Sterility. 96(1). 15–18. 6 indexed citations

Casson, Peter R., Stephen A. Krawetz, Michael P. Diamond, et al.. (2011). Proactively Establishing a Biologic Specimens Repository for Large Clinical Trials: An Idea Whose Time has Come. Systems Biology in Reproductive Medicine. 57(5). 217–221. 5 indexed citations

10.

Diamond, Michael P., Robert F. Casper, Joel W. Ager, et al.. (2011). Estimating rates of multiple gestation pregnancies: Sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial. Contemporary Clinical Trials. 32(6). 902–908. 33 indexed citations

11.

Krawetz, Stephen A., Peter R. Casson, Michael P. Diamond, et al.. (2011). Establishing a Biologic Specimens Repository for Reproductive Clinical Trials: Technical Aspects. Systems Biology in Reproductive Medicine. 57(5). 222–227. 6 indexed citations

12.

Zhang, Heping, Richard S. Legro, Jian Zhang, et al.. (2010). Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Human Reproduction. 25(10). 2612–2621. 26 indexed citations

13.

Nachtigall, Lila E., et al.. (2010). Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecological Endocrinology. 27(1). 39–48. 58 indexed citations

14.

Toth, Michael J., Brian C. Cooper, Richard E. Pratley, et al.. (2008). Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. American Journal of Physiology-Endocrinology and Metabolism. 294(6). E1035–E1045. 11 indexed citations

15.

Cooper, Brian C., Cynthia K. Sites, Peter R. Casson, & Michael J. Toth. (2007). Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertility and Sterility. 87(5). 1131–1138. 10 indexed citations

16.

Casson, Peter R.. (2000). Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction. 15(10). 2129–2132. 186 indexed citations

17.

Pisarska, Margareta D., Peter R. Casson, Pauline Cisneros, et al.. (1999). Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytes. Fertility and Sterility. 71(4). 627–632. 49 indexed citations

18.

Bates, G. Wright, Robert Egerman, Edward S. Umstot, John E. Buster, & Peter R. Casson. (1995). Dehydroepiandrosterone Attenuates Study‐Induced Declines in Insulin Sensitivity in Postmenopausal Women^a. Annals of the New York Academy of Sciences. 774(1). 291–293. 21 indexed citations

19.

Casson, Peter R., Richard N. Andersen, Henry G. Herrod, et al.. (1993). Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. American Journal of Obstetrics and Gynecology. 169(6). 1536–1539. 158 indexed citations

20.

Casson, Peter R., Philip M. Hahn, Dean A. Van Vugt, & Robert L. Reid. (1990). Lasting response to ovariectomy in severe intractable premenstrual syndrome. American Journal of Obstetrics and Gynecology. 162(1). 99–105. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact